ストックスクリーナーアプリを入手
16.03
1.72%
0.2074
前日終値:
$15.82
開ける：
$15.7743
24時間の取引高:
5.21M
Relative Volume:
0.24
時価総額：
$3.65B
収益：
$1.78B
当期純損益:
$164.40M
株価収益率:
23.23
EPS:
0.69
ネットキャッシュフロー:
$236.51M
1週間 パフォーマンス:
+1.72%
1か月 パフォーマンス:
-46.86%
6か月 パフォーマンス:
-64.52%
1年 パフォーマンス:
-61.58%
1日の値動き範囲:
$15.60
$16.36
1週間の範囲:
$13.74
$16.46
52週間の値動き範囲:
$13.74
$70.43
Hims Hers Health Inc Stock (HIMS) Company Profile
Compare HIMS vs TAK, ZTS, HLN, TEVA, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
16.02 | 3.61B | 1.78B | 164.40M | 236.51M | 0.69 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.52 | 58.79B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
130.19 | 54.43B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.76 | 46.49B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.89 | 39.16B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
509.99 | 23.04B | 3.13B | 1.27B | 1.12B | 26.39 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-12 | 開始されました | Evercore ISI | In-line |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-10-21 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | ダウングレード | Needham | Buy → Hold |
| 2025-06-04 | 繰り返されました | Needham | Buy |
| 2025-04-29 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | ダウングレード | Citigroup | Neutral → Sell |
| 2025-01-07 | 開始されました | BTIG Research | Buy |
| 2024-12-17 | 開始されました | Morgan Stanley | Overweight |
| 2024-11-14 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-08-22 | 開始されました | Needham | Buy |
| 2024-08-09 | ダウングレード | Imperial Capital | Outperform → In-line |
| 2024-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-04-16 | ダウングレード | Jefferies | Buy → Hold |
| 2024-04-10 | 開始されました | Canaccord Genuity | Buy |
| 2024-02-28 | アップグレード | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2023-12-07 | 開始されました | Imperial Capital | In-line |
| 2023-07-28 | 開始されました | TD Cowen | Outperform |
| 2023-04-11 | 開始されました | Robert W. Baird | Neutral |
| 2023-02-09 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-11-08 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-07-15 | 開始されました | SVB Leerink | Underperform |
| 2022-04-14 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-03-10 | 開始されました | Deutsche Bank | Hold |
| 2021-12-02 | 開始されました | Jefferies | Hold |
| 2021-11-11 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 開始されました | BofA Securities | Neutral |
| 2021-05-20 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 開始されました | Truist | Hold |
| 2021-03-09 | 開始されました | Credit Suisse | Neutral |
| 2021-03-02 | アップグレード | Citigroup | Neutral → Buy |
| 2021-02-17 | 開始されました | Citigroup | Neutral |
| 2021-02-12 | 開始されました | Piper Sandler | Neutral |
| 2021-02-08 | 開始されました | Tigress Financial | Buy |
すべてを表示
Hims Hers Health Inc (HIMS) 最新ニュース
The Law Offices of Frank R. Cruz Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors - The AI Journal
Hims & Hers Posts Robust Growth Boosted by New Acquisition - timothysykes.com
HIMS vs. AMWL: Which Telehealth Stock Is the Better Investment Now? - The Globe and Mail
Barclays Lowers Price Target for HIMS to $25, Maintains Overweig - GuruFocus
Morgan Stanley Lowers Price Target for HIMS to $21 | HIMS Stock News - GuruFocus
Hims & Hers Health: The GLP-1 Party Is Over (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health, Inc. (NYSE:HIMS) Q4 2025 Earnings Call Transcript - Insider Monkey
Discipline and Rules-Based Execution in HIMS Response - Stock Traders Daily
Hims And Hers Balances GLP 1 Scrutiny With Eucalyptus Expansion Plans - Yahoo Finance
Regulatory Scrutiny of Compounded Drugs Puts Hims & Hers’ Growth, Partnerships, and Liability Risk in the Spotlight - TipRanks
Bronstein, Gewirtz & Grossman, LLC Is Investigating Hims & Hers Health, Inc. (HIMS) And Encourages Shareholders to Connect - ACCESS Newswire
Hims & Hers Earnings Call Signals Growth Amid Risks - TipRanks
These Stocks Are Today’s Movers: AMD, Hims & Hers, Keysight, IBM, Kratos, Vir Biotechnology, Whirlpool, and More - Barron's
Earnings live: Home Depot stock climbs after earnings beat, Hims & Hers slides, Constellation Energy rises - Yahoo Finance
HIMS Analyst Rating Update: Leerink Partners Lowers Price Target - GuruFocus
Hims & Hers Health: Don't Get Lost In The Weeds (NYSE:HIMS) - Seeking Alpha
HIMS: Analyst TD Cowen Lowers Price Target to $17.00 | HIMS Stoc - GuruFocus
Hims & Hers Health: Great Vision, Now On Sale -- Here's Why I'm Upgrading (NYSE:HIMS) - Seeking Alpha
HIMS Analyst Rating Update: Citigroup Lowers Price Target | HIMS Stock News - GuruFocus
Hims & Hers Stock Faces Heavy Sell-Off Amid SEC Probe Into GLP-1 Disclosures - GuruFocus
HIMS Stock Plummets After Wall Street Downgrade, Price Target Cuts Following 'Disappointing' Q4 Report - Stocktwits
HIMS: BTIG Downgrades Hims & Hers Health to Neutral | HIMS Stock News - GuruFocus
Jefferies holds Hims and Hers stock rating at Hold on guidance concerns - Investing.com Nigeria
Hims & Hers Health Analysts Cut Their Forecasts After Q4 Results - Benzinga
Hims & Hers Stock Slips Despite Q4 Earnings Beat, Margins Contract - Yahoo Finance
AMD, Hims & Hers, Keysight, Novo Nordisk, IBM, Kratos, Vir, and More Movers - Barron's
Truist Securities Reiterates Hold Rating on HIMS, Lowers Price T - GuruFocus
Truist cuts Hims and Hers stock price target on quarterly ramp concerns - Investing.com India
Evercore ISI Group Lowers Price Target for Hims & Hers Health (H - GuruFocus
Hims & Hers Health (HIMS) Stock Plunges 7-9% to Near $14 After Soft Q1 2026 Guidance Despite Q4 Beat - International Business Times Australia
Hims & Hers Faces Investor Scrutiny Amid Regulatory and Growth Challenges - AD HOC NEWS
Biggest stock movers Tuesday: HIMS, VIR, CLVT, and more - Seeking Alpha
Hims & Hers Stock Drops. Why Earnings Are Underwhelming Investors. - Barron's
AMD, Hims & Hers, Home Depot, Kratos, Novo Nordisk, IBM, Keysight, Vir Biotechnology, and More Movers - Barron's
Meta, AMD announce chip partnership, Novo Nordisk cuts US GLP-1 prices - Yahoo Finance
KeyBanc maintains Hims and Hers stock rating on revenue outlook - Investing.com
Hims & Hers in Free Fall: Why Analysts See Nearly 150% Upside - Investing.com
Hims & Hers Health Stock (HIMS) Opinions on Q4 Earnings Release - Quiver Quantitative
Novo Nordisk: Investors Focusing On CagriSema Results Are Missing The Big Picture (NVO) - Seeking Alpha
Hims & Hers Health After The GLP-1 Collapse - Seeking Alpha
Hims & Hers Stock StumblesCautions About Pressure Due To Super Bowl Ad, Change In Shipping Cadences - Benzinga
Hims & Hers Health, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Earnings live: Hims & Hers stock slides, Domino's rises as investors await crucial update from Nvidia - Yahoo Finance
AMD, Home Depot, Novo Nordisk, Hims & Hers, Keysight, Vir Biotechnology, and More Movers - Barron's
Deutsche Bank Adjusts Hims & Hers Health Price Target to $25 From $31, Maintains Hold Rating - marketscreener.com
Home Depot, Novo Nordisk, Hims & Hers, IBM, BWX, and More Stock Market Movers - Barron's
Hims Expands Globally, Guides Higher - GuruFocus
Truist Securities Adjusts PT on Hims & Hers Health to $18 From $37, Maintains Hold Rating - marketscreener.com
Evercore ISI cuts Hims and Hers stock price target on growth concerns - Investing.com
Hims & Hers Snaps EPS Losing Streak but Shares Still in Free Fall - Yahoo Finance
Hims & Hers Q4 Earnings Show Growth Amid GLP-1 Scrutiny (NYSE:HIMS) - Seeking Alpha
Hims Hers Health Inc (HIMS) 財務データ
収益
当期純利益
現金流量
EPS
0.55%
1.67%
大文字化:
|
ボリューム (24 時間):